HOME >> MEDICINE >> NEWS
National research network launched to seek better treatments for brain injury, stroke and seizures

ANN ARBOR, Mich. Every twenty-eight seconds, someone in America suffers a stroke, a massive seizure, a brain or spinal cord injury, or another major emergency affecting the brain, spine or nerves. Every two minutes, someone dies from one of these conditions. Many others are left permanently disabled.

To reduce this toll, it will take better treatments that can be delivered in the first minutes and hours after neurological emergencies occur. But many barriers stand in the way of studying new treatments in enough patients to show how well they work.

This week, a team of researchers from around the country will gather in Michigan to kick off an unprecedented national effort to break down those barriers. The meeting will officially launch the Neurological Emergencies Treatment Trials network, or NETT, which will be a permanent backbone that will allow a broad variety of studies to be conducted in ambulances and hospitals nationwide.

The network is funded by a $7.7 million, five-year grant from the National Institute for Neurological Diseases and Stroke, part of the National Institutes of Health.

Because it involves so many sites where brain and spine emergencies are treated, NETT will overcome one of the biggest roadblocks to finding better emergency treatments: having enough eligible patients with the same condition at any single hospital. By studying patients at many hospitals, NETT will gather information on what works, and what doesn't, faster than ever before and share that knowledge so that all patients can benefit.

The University of Michigan Health System is the home to the NETT's clinical coordinating center, which will coordinate the network's 11 "hub" centers at major medical centers. Each of those hubs will partner with many "spoke" hospitals and emergency medical response companies around the country.

This week's kickoff is something that Bill Barsan, M.D., has been working toward for mor
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
29-Jan-2007


Page: 1 2 3 4

Related medicine news :

1. National quality agenda, payment reform, care integration keys to improving quality, patient safety
2. National Academies Advisory -- June 8 public briefing on LANL groundwater protection
3. Story tips from the Department of Energys Oak Ridge National Laboratory, May 2007
4. National Autism Conference slated for June
5. National Academy of Sciences Institute of Medicine report calls for more dairy foods at school
6. Annual meeting of the National Academy of Sciences
7. National experts and nonprofit organizations call to end FDA user fees and to improve drug safety
8. National Institute of Dental and Craniofacial Research activities
9. National addiction treatment leaders to meet at first NIATx Summit
10. K-State National Agricultural Biosecurity Center director speaker at AAAS Biosecurity Symposium
11. National Inventors Hall of Fame announces 2007 inductees

Post Your Comments:
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... 23, 2013 Jeanne Ettelson, president of ... its popular and only free OCD support group in ... resource for OCD sufferers, the group is lead by ... disorders. This allows group participants to learn accurate ... Response Prevention. , “Participants in Beyond OCD’s support ...
(Date:5/23/2013)... News) -- The sensation of itching is hardwired into ... a small molecule released in the spinal cord, according ... say this molecule, known as natriuretic polypeptide b (Nppb), ... system. Ultimately, this signal is experienced as an itch. ... similar, the researchers concluded that a similar process probably ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Although a study ... the thinking and memory problems associated with Alzheimer,s ... have been unable to duplicate those findings. ... implications for patient safety since the drug involved ... effects, such as major blood-lipid abnormalities, pancreatitis, headaches, ...
(Date:5/23/2013)... Netsmart today announced it is ranked #49 ... technology (HIT) providers for 2013. , The HCI 100 listing ... Informatics magazine. Netsmart’s ranking of #49 is up from ... is largely due to our commitment to helping organizations forge ... resources are scarce, the demand for care is unprecedented and ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Netsmart Named to Healthcare Informatics Top 100 List 2
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE ( Europe ... Glasgow Science Centre in Scotland , ... the SynCardia temporary Total Artificial Heart powered ... $3 million Bodyworks Exhibition, one of the most advanced ...
(Date:5/23/2013)... May 23, 2013 InspireMD, ... the leader in embolic protection stents, today announced ... Acute ST Elevation Reperfusion) trial demonstrating that the ... and drug eluting stents in all-cause mortality in ... from the trial were presented at the InspireMD ...
(Date:5/23/2013)... 2013  PAREXEL International Corporation (NASDAQ: PRXL ... the Jefferies Healthcare Conference in New York.  ... Financial Officer, will be making a presentation on PAREXEL ... June 3, 2013. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
Breaking Medicine Technology:Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5PAREXEL International To Present At Jefferies Healthcare Conference 2
Cached News: